CIK 0001001250 · Large accelerated filer
ESTEE LAUDER COMPANIES INC
Sign in to watch- Ticker
- EL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112408943
- Phone
- 2125724200
- Business address
- 767 FIFTH AVE, NEW YORK, NY, 10153
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,667,510
- in 9 filings
Net −$24,667,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-25 | MOSS SARA E Vice Chairman | Gift | −5,975 | 3,915 | ||
| 2022-02-25 | MOSS SARA E Vice Chairman | Gift | +5,975 | 50,377 | ||
| 2022-02-23 | Christianson Wei Sun Director | Gift | −340 | 6,743.64 | ||
| 2022-02-15 | Haney Carl P. EVP Research Prod & Innovation | Sale | −1,152 | $307.94 | $355K | 6,480 |
| 2022-02-10 | LAUDER RONALD S Chairman, Clinique Labs, LLC | Conversion | +700,000 | 700,000 | ||
| 2022-02-10 | LAUDER RONALD S Chairman, Clinique Labs, LLC | Sale | −700,000 | $307.08 | $215.0M | 0 |
| 2022-02-10 | LAUDER RONALD S Chairman, Clinique Labs, LLC | Conversion · Class B Common Stock | −700,000 | 4,768,846 | ||
| 2022-02-09 | Demsey John Group President | Option exercise | +10,027 | $218.06 | $2.2M | 16,634 |
| 2022-02-09 | Demsey John Group President | Sale | −10,027 | $319.68 | $3.2M | 6,607 |
| 2022-02-09 | Demsey John Group President | Option exercise · Option (right to buy) | −10,027 | 20,054 |
Page 57 of 57 · 1,130 trades